Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assay
On Jun. 9, 2020, Quidel announced that is had received an amended Emergency Use Authorization (EUA) from the…
-
-
Up to 45 percent of SARS-CoV-2 infections may be asymptomatic, new analysis found
On Jun. 9, 2020, researchers from Scripps report that an extraordinary percentage of people infected by the virus…
-
OpGen released preliminary data demonstrating Unyvero HPN panel for pneumonia identified life-threatening bacterial co-infections in COVID-19 patients
On Jun. 9, 2020, OpGen announced preliminary data from an investigator initiated collaboration with Karolinska Institutet, Stockholm, Sweden,…
-
Immunic announced FDA allowance of its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 9, 2020, Immunic announced receipt of regulatory allowance from the FDA to initiate its phase 2,…
-
Aegis Sciences testing for Coronavirus 2019 authorized to report in all 50 states
On Jun. 9, 2020, Aegis Sciences announced that it was registered and approved to provide public health reporting…
-
Emergency COVID-19 measures prevented more than 500 million infections
On Jun. 8, 2020, emergency health measures implemented in six major countries have ‘significantly and substantially slowed’ the…
-
Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology
On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…
-
Lilly announced start of phase 1 study for its second potential COVID-19 antibody treatment
On Jun. 8, 2020, Eli Lilly announced its partner Junshi Biosciences had dosed the first healthy volunteer in…
-
OraSure’s Oragene-Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
On Jun. 8, 2020, OraSure Technologies announced that Phosphorus Diagnostics, a leader in diagnostic and bioinformatic solutions for…
-
The US Department of Defense established collaborative virus genetic sequencing capability for COVID-19
On Jun. 6, 2020, to jumpstart the Department of Defense’s (DoD) SARS-CoV-2 sequencing efforts, Armed Forces Health Surveillance…
-
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…
-
Sorrento announced COVIDTRAP(STI-4398) demonstrated in preclinical studies its ability to completely inhibit SARS-CoV-2 viral infection In vitro
On Jun. 5, 2020, Sorrento announced it had completed a preclinical batch of the STI-4398 (COVIDTRAP) protein and…
-
University of Queensland, CEPI and CSL partnered to advance development of COVID-19 vaccine candidate
On Jun. 5, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ)…
-
Unique biorepository stores samples from Alberta COVID-19 patients for future research
On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…
-
Study identified potential approach to treat severe respiratory distress in patients with COVID-19
On Jun. 5, 2020, early data from a clinical study suggested that blocking the Bruton tyrosine kinase (BTK)…
-
Calquence showed promising clinical improvement in majority of 19 hospitalised COVID-19 patients
On Jun. 5, 2020, results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK)…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Measles | Polio | Vaccine
World leaders made historic commitments to provide equal access to vaccines for all
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
-
WHO welcomed crucial new funding for vaccines
On Jun. 4, 2020, the World Health Organization (WHO) welcomed funding commitments from Gavi, the Vaccine Alliance’s third…
-
The UK Global Vaccine Summit secured $74 billion in funding to support global vaccine supply and immunisation
On Jun. 4, 2020, the United Kingdom (UK) helped secure $7.4 billion in funding to support global vaccine…
-
The Gates Foundation pledged $1.6 billion to Gavi, the Vaccine Alliance, to protect the next generation with vaccines
On Jun. 4, 2020, the Bill & Melinda Gates Foundation announced a five-year, US$1.6 billion commitment to Gavi,…
-
Introduction and spread of SARS-CoV-2 in the greater Boston area
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
-
Novavax awarded Department of Defense contract for COVID-19 vaccine
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
-
Successful detailed tracking of major plant disease’s global spread
On Jun. 4, 2020, Agricultural Research Service scientists and their Oregon State University collaborators announced they had developed…
-
INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
-
iBio announced second COVID-19 vaccine program
On Jun. 4, 2020, iBio announced initiation of preclinical immunization studies for its second COVID-19 vaccine platform. The…
-
Virginia Tech researchers established a reverse genetics system to facilitate COVID-19 research
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
-
Roche initiated initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On Jun. 4, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
-
HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries
On Jun. 3, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax have pledged…
-
CEPI granted $141 million to consortium of Bharat Biotech and IVI to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
-
NIH reported early results show benefit of remdesivir for COVID-19
On Jun. 2, 2020, the National Institutes of Health (NIH) reported that early results showed that remdesivir benefited…
